Versigent (VGNT) – Research Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Versigent (NYSE: VGNT):

• 5/7/2026 – Versigent had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $38.00 price target on the stock.
• 5/6/2026 – Versigent had its price target raised by UBS Group AG from $43.00 to $49.00. They now have a “buy” rating on the stock.
• 5/6/2026 – Versigent had its price target raised by TD Cowen from $47.00 to $49.00. They now have a “buy” rating on the stock.
• 5/6/2026 – Versigent had its price target raised by Wells Fargo & Company from $35.00 to $42.00. They now have an “overweight” rating on the stock.
• 4/30/2026 – Versigent is now covered by Wolfe Research. They set an “outperform” rating and a $53.00 price target on the stock.
• 4/28/2026 – Versigent is now covered by BNP Paribas Exane. They set an “outperform” rating and a $41.00 price target on the stock.
• 4/28/2026 – Versigent is now covered by Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $35.00 price target on the stock.
• 4/21/2026 – Versigent is now covered by Evercore Inc. They set an “outperform” rating and a $55.00 price target on the stock.
• 4/18/2026 – Versigent was upgraded by Wall Street Zen to “hold”.
• 4/16/2026 – Versigent was upgraded by Zacks Research to “hold”.
• 4/14/2026 – Versigent is now covered by TD Cowen. They set a “buy” rating and a $47.00 price target on the stock.
• 4/14/2026 – Versigent is now covered by UBS Group AG. They set a “buy” rating and a $43.00 price target on the stock.
• 4/14/2026 – Versigent is now covered by UBS Group AG. They set a “buy” rating and a $43.00 price target on the stock.
• 4/14/2026 – Versigent is now covered by TD Cowen. They set a “buy” rating and a $47.00 price target on the stock.
• 4/7/2026 – Versigent was upgraded by Fox Advisors to “strong-buy”.
• 4/6/2026 – Versigent is now covered by Wells Fargo & Company. They set an “overweight” rating and a $35.00 price target on the stock.
• 3/31/2026 – Versigent is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $28.00 price target on the stock.